A Study of TAK-662 for Japanese Patients With Congenital Protein C Deficiency

NCT04984889 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Protein C Deficiency

Interventions

DRUG: TAK-662

Sponsor

Takeda